Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2025

Feb 5, 2025

60507_rns_2025-02-05_4fd0b1ef-2891-4863-806e-04a54e412ece.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 41] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

February 5, 2025

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we wish to inform you that, the Company has received an Order on February 4, 2025, from the Office of the Assistant Commissioner, CGST, Division-IV (Narol), Ahmedabad South (“Order”), basis the GST Audit conducted by the Department for the period July 2017 to March 2020 in the state of Gujarat, for a tax demand of Rs. 27,50,988/- and a Penalty of Rs. 27,50,988/- aggregating to a total demand of Rs. 55,01,976/-.

Based on our assessment, we believe that the said demand is not maintainable and the Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.

Additional details required to be disclosed pursuant to the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited

PRAJEET Digitally signed by PRAJEET NAIR NAIR Date: 2025.02.05 17:33:14 +05'30' Prajeet Nair Director – Corporate Services & Company Secretary

Encl.: A/a

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Annexure A

Additional information pursuant to SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sr.No. Particulars Details
1. Name of Authority The Office of the Assistant Commissioner, CGST,Division-IV(Narol),Ahmedabad South.
2. Nature and details of the action(s)taken, initiated or order(s) passed. OrderRefNo.ZD240225013293XdatedFebruary 4, 2025, passed under Section 74 of theCGSTAct,2017forataxdemandofRs. 27,50,988/- and a Penalty of Rs. 27,50,988/-aggregatingto a total demand of Rs. 55,01,976/-.
3. Date of receipt of direction ororder, including any ad-interim orinterim orders, or any othercommunicationfromtheauthority. February 4, 2025
4. Detailsoftheviolation(s)/contravention(s)committedoralleged to be committed. The Authority has alleged that the Company hasavailed excess Input Tax Credit.
5. Impact on financial, operation orother activities of the listed entity,quantifiable in monetary terms tothe extent possible. There is no material impact on financials, operationsor other activities of the Company.The Company believes that the said demand is notmaintainable and is in the process of preferring anappeal against the said order/demand.